Covered recipient · General Payments record
GREGORY T FOUNTAIN
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2021
$1,601.88
- Reported across 90 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $534.07 | 27 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $215.42 | 9 |
| Exeltis, USA Inc. | $78.74 | 5 |
| Astellas Pharma US Inc | $71.98 | 4 |
| MAYNE PHARMA COMMERCIAL LLC | $49.12 | 2 |
| PFIZER INC. | $21.31 | 1 |
| MILLICENT US INC | $20.07 | 1 |
| Organon LLC | $18.96 | 1 |
| TherapeuticsMD, Inc. | $18.53 | 1 |
| Mylan Pharmaceuticals Inc. | $13.95 | 1 |
| Myovant Sciences Inc. | $13.01 | 1 |
| Amgen Inc. | $12.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (27)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $26.25 | 01/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794499681 | CMS |
| AbbVie Inc. | $28.51 | 01/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794499685 | CMS |
| AbbVie Inc. | $25.11 | 04/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794499689 | CMS |
| AbbVie Inc. | $18.84 | 06/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794499693 | CMS |
| AbbVie Inc. | $19.86 | 06/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794499697 | CMS |
| AbbVie Inc. | $29.86 | 07/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794499699 | CMS |
| AbbVie Inc. | $20.31 | 08/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794499703 | CMS |
| AbbVie Inc. | $28.88 | 09/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794499707 | CMS |
| AbbVie Inc. | $17.80 | 09/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794499711 | CMS |
| Amgen Inc. | $12.98 | 01/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825340103 | CMS |
| Astellas Pharma US Inc | $17.97 | 04/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 821324349 | CMS |
| Astellas Pharma US Inc | $18.87 | 05/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 821324355 | CMS |
| Astellas Pharma US Inc | $17.57 | 07/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 821324359 | CMS |
| Astellas Pharma US Inc | $17.57 | 09/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 821324365 | CMS |
| Exeltis, USA Inc. | $17.16 | 03/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 806193537 | CMS |
| Exeltis, USA Inc. | $14.80 | 05/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 806197983 | CMS |
| Exeltis, USA Inc. | $15.00 | 06/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 806193543 | CMS |
| Exeltis, USA Inc. | $16.34 | 08/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 806202891 | CMS |
| Exeltis, USA Inc. | $15.44 | 09/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 806193539 | CMS |
| MAYNE PHARMA INC. | $22.61 | 07/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 849462537 | CMS |
| MAYNE PHARMA INC. | $26.51 | 09/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 849503807 | CMS |
| MILLICENT US INC | $20.07 | 02/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 780880473 | CMS |
| Mylan Pharmaceuticals Inc. | $13.95 | 04/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 965460885 | CMS |
| Myovant Sciences Inc. | $13.01 | 08/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 834954273 | CMS |
| Organon LLC | $18.96 | 06/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 837225151 | CMS |
| PFIZER INC. | $21.31 | 07/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 832706781 | CMS |
| TherapeuticsMD, Inc. | $18.53 | 02/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 844910301 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.